US2022387327A1PendingUtilityA1
Method of manufacturing pharmaceutical compositions
Assignee: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTDPriority: Nov 27, 2013Filed: Aug 18, 2022Published: Dec 8, 2022
Est. expiryNov 27, 2033(~7.3 yrs left)· nominal 20-yr term from priority
A61K 9/2018A61K 9/2095A61P 13/12A61K 9/0056A61K 9/2009A61K 33/26A61K 9/2059A61K 9/14A61P 3/00A61K 9/2072
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to pharmaceutical composition, comprising certain phophate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition, comprising a phosphate binder, said phosphate binder comprises particles having a particle size distribution, wherein at least 40% of the particles have a particle size within the range of 4 to 200 μm, d50 is in the range of between 30 μm to 120 μm, and wherein the phosphate binder particles comprise a mixture of iron(III)-oxyhydroxide, sucrose and one or more starches.
2 - 26 . (canceled)Join the waitlist — get patent alerts
Track US2022387327A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.